Table 3.
Quartile of Intake | No. of Controls | EBV-positive Diseasea |
EBV-negative Diseasea |
||||
No. of Cases | OR | 95% CI | No. of Cases | OR | 95% CI | ||
Folate, μg/day | |||||||
Total | |||||||
Q1 | 159 | 20 | 1.00 | Referent | 73 | 1.00 | Referent |
Q2 | 160 | 19 | 1.08 | 0.54, 2.14 | 59 | 0.82 | 0.54, 1.25 |
Q3 | 161 | 16 | 0.93 | 0.45, 1.92 | 80 | 1.20 | 0.80, 1.79 |
Q4 | 158 | 26 | 1.61 | 0.83, 3.11 | 74 | 1.21 | 0.80, 1.83 |
Ptrend | 0.16 | 0.10 | |||||
From food | |||||||
Q1 | 160 | 17 | 1.00 | Referent | 64 | 1.00 | Referent |
Q2 | 159 | 23 | 1.41 | 0.72, 2.79 | 75 | 1.24 | 0.83, 1.86 |
Q3 | 161 | 22 | 1.57 | 0.78, 3.17 | 81 | 1.35 | 0.90, 2.02 |
Q4 | 158 | 19 | 1.32 | 0.64, 2.70 | 66 | 1.16 | 0.76, 1.77 |
Ptrend | 0.44 | 0.56 | |||||
Vitamin B2, mg/day | |||||||
Total | |||||||
Q1 | 160 | 17 | 1.00 | Referent | 72 | 1.00 | Referent |
Q2 | 160 | 17 | 1.05 | 0.50, 2.19 | 53 | 0.73 | 0.47, 1.12 |
Q3 | 160 | 19 | 1.19 | 0.57, 2.48 | 86 | 1.31 | 0.87, 1.97 |
Q4 | 158 | 28 | 1.94 | 0.99, 3.80 | 75 | 1.19 | 0.79, 1.79 |
Ptrend | 0.04 | 0.07 | |||||
From food | |||||||
Q1 | 160 | 17 | 1.00 | Referent | 67 | 1.00 | Referent |
Q2 | 159 | 20 | 1.25 | 0.62, 2.52 | 73 | 1.09 | 0.72, 1.63 |
Q3 | 162 | 17 | 1.04 | 0.51, 2.16 | 80 | 1.17 | 0.78, 1.74 |
Q4 | 157 | 27 | 1.74 | 0.90, 3.40 | 66 | 1.05 | 0.69, 1.58 |
Ptrend | 0.10 | 0.89 | |||||
Vitamin B6, mg/day | |||||||
Total | |||||||
Q1 | 159 | 23 | 1.00 | Referent | 62 | 1.00 | Referent |
Q2 | 159 | 17 | 0.78 | 0.39, 1.56 | 74 | 1.31 | 0.86, 2.00 |
Q3 | 162 | 15 | 0.73 | 0.35, 1.51 | 70 | 1.29 | 0.84, 1.99 |
Q4 | 158 | 26 | 1.33 | 0.70, 2.53 | 80 | 1.62 | 1.06, 2.47 |
Ptrend | 0.25 | 0.03 | |||||
From food | |||||||
Q1 | 160 | 20 | 1.00 | Referent | 67 | 1.00 | Referent |
Q2 | 159 | 19 | 1.05 | 0.53, 2.08 | 78 | 1.24 | 0.83, 1.86 |
Q3 | 160 | 18 | 1.03 | 0.52, 2.07 | 79 | 1.26 | 0.84, 1.89 |
Q4 | 159 | 24 | 1.45 | 0.74, 2.83 | 62 | 1.11 | 0.72, 1.69 |
Ptrend | 0.28 | 0.75 | |||||
Vitamin B12, μg/day | |||||||
Total | |||||||
Q1 | 161 | 18 | 1.00 | Referent | 57 | 1.00 | Referent |
Q2 | 158 | 19 | 1.13 | 0.56, 2.28 | 71 | 1.33 | 0.87, 2.04 |
Q3 | 162 | 24 | 1.41 | 0.72, 2.78 | 77 | 1.48 | 0.97, 2.26 |
Q4 | 157 | 20 | 1.20 | 0.59, 2.44 | 81 | 1.75 | 1.15, 2.68 |
Ptrend | 0.86 | 0.02 | |||||
From food | |||||||
Q1 | 161 | 18 | 1.00 | Referent | 60 | 1.00 | Referent |
Q2 | 157 | 21 | 1.27 | 0.64, 2.53 | 70 | 1.22 | 0.81, 1.86 |
Q3 | 163 | 20 | 1.24 | 0.62, 2.48 | 84 | 1.42 | 0.95, 2.14 |
Q4 | 157 | 22 | 1.35 | 0.68, 2.67 | 72 | 1.37 | 0.90, 2.09 |
Ptrend | 0.45 | 0.15 | |||||
Methionine, g/day | |||||||
From food | |||||||
Q1 | 160 | 25 | 1.00 | Referent | 66 | 1.00 | Referent |
Q2 | 159 | 23 | 0.98 | 0.52, 1.84 | 77 | 1.20 | 0.80, 1.81 |
Q3 | 161 | 21 | 0.96 | 0.51, 1.83 | 72 | 1.08 | 0.71, 1.63 |
Q4 | 158 | 12 | 0.53 | 0.25, 1.12 | 71 | 1.13 | 0.75, 1.71 |
Ptrend | 0.12 | 0.66 | |||||
Current multivitamin useb | |||||||
No | 368 | 49 | 1.00 | Referent | 144 | 1.00 | Referent |
Yes | 264 | 30 | 0.98 | 0.59, 1.62 | 139 | 1.46 | 1.09, 1.96 |
Ptrend | 0.92 | 0.01 |
Abbreviations: CI, confidence interval; EBV, Epstein-Barr virus; OR, odds ratio; Q, quartile.
Adjusted for age (5-year age groups), sex (male, female), state of residence (Connecticut, Massachusetts), total energy intake (continuous), smoking history (ever, never), and education (less than high school, high school, college, advanced degree).
Excludes 13 participants missing current multivitamin use.